By Drug Target Review2025-02-26T09:00:36
A study by the University of Surrey suggests that amlodipine, a common blood pressure medication, could be repurposed as a safer, more accessible treatment for ADHD. This offers a promising alternative to current medications and highlights the potential of drug repurposing in advancing treatment options.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-31T14:05:00Z
2023-07-04T09:00:08
Sponsored by SB Drug Discovery
2025-11-13T14:00:00
Sponsored by Cell Signaling Technology
2023-12-11T10:49:07
Sponsored by Leica Microsystems
2025-07-30T08:00:00
Sponsored by Wuxi Biologics
2025-05-08T10:38:52
Sponsored by Takara Bio USA
2023-04-12T15:28:08
Sponsored by nanoComposix
Site powered by Webvision Cloud